Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12001977Phase 4Completed
Phase 4, randomised, open-label trial of valproic acid in epilepsy (2 arms), sponsored by Huashan Hospital. Primary endpoint: Epileptic attack. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12001977.